Extended Duration of Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Long Is Too Long?

Extended Duration of Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Long Is Too Long?

Bibliographic Details
Main Authors:	Charles E. Howard, Vijay Nambi, Hani Jneid, Umair Khalid
Format:	Article
Language:	English
Published:	Wiley 2019-10-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	acute coronary syndrome drug‐eluting stent dual‐antiplatelet therapy guideline
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.119.012639

Similar Items

Long‐Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second‐Generation Drug‐Eluting Stents: The Veterans Affairs Extended DAPT Study
by: Scott Kinlay, et al.
Published: (2023-01-01)

Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials
by: Mahmoud Barbarawi, et al.
Published: (2019-01-01)

Long-term outcomes following drug-eluting balloon or thin-strut drug-eluting stents for treatment of in-stent restenosis stratified by duration of dual antiplatelet therapy (DEB-Dragon Registry)
by: Rafał Januszek, et al.
Published: (2022-04-01)

Importance of Short-Term Neointimal Coverage of Drug-Eluting Stents in the Duration of Dual Antiplatelet Therapy
by: Joanna Fluder-Wlodarczyk, et al.
Published: (2024-03-01)

Fifteen-Year Nationwide Trend in Antiplatelet Treatment among Drug-Eluting Stent Recipients in Korea: Many Patients Receive Very Prolonged Dual-Antiplatelet Treatment, and Newer Drugs Are Replacing the Older Ones
by: Sunwon Kim, et al.
Published: (2023-04-01)

Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long‐Term Outcomes
by: Scott Kinlay, et al.
Published: (2021-05-01)

OPTIMA Tacrolimus-eluting Stent: A Twelve-month Clinical Follow up with Two Different Periods of Dual Antiplatelet Therapy; 2-monthvs. 6-month Approach
by: Nasser Aslanabadi, et al.
Published: (2012-09-01)

The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent
by: Mengjin Hu, et al.
Published: (2022-07-01)

Clinical Impact of Dual Antiplatelet Therapy Use in Patients Following Everolimus-eluting Stent Implantation: Insights from the SEEDS Study
by: Yao-Jun Zhang, et al.
Published: (2015-01-01)

Can antiplatelet therapy after drug eluting stent become a problem?
by: Michele Romano
Published: (2009-03-01)

Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation
by: Vassilis Voudris, et al.
Published: (2014-12-01)

Dual Antiplatelet Therapy: A Concise Review for Clinicians
by: Hafeez Ul Hassan Virk, et al.
Published: (2023-07-01)

Walking the Line with Ticagrelor: Meta-Analysis Comparing the Safety and Efficacy of Ticagrelor Monotherapy after a Short Course of Ticagrelor-Based Dual Antiplatelet Therapy versus Standard Therapy in Complex Percutaneous Coronary Intervention
by: Francesco Condello, et al.
Published: (2021-11-01)

Case‐fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta‐analysis
by: Tobias Tritschler, et al.
Published: (2022-10-01)

Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI
by: Hao-Yu Wang, et al.
Published: (2021-05-01)

Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with diabetes mellitus: A nationwide retrospective cohort study
by: Seung-Jun Lee, et al.
Published: (2022-08-01)

An epidural catheter removal after recent percutaneous coronary intervention and coronary artery stenting: Epidural catheter and antiaggregation therapy
by: Joksić Nikola, et al.
Published: (2016-01-01)

Clinical benefit of long-term use of dual antiplatelet therapy for acute myocardial infarction patients with the PEGASUS-TIMI 54 criteria
by: Kwan Yong Lee, et al.
Published: (2022-11-01)

THE EFFECTS OF SHORT/LONG-TERM ADMINISTRATION OF DUAL ANTIPLATELET THERAPY ON RESTENOSIS IN PATIENTS WITH CAROTID ARTERY STENTING
by: İsmail Karluka, et al.
Published: (2022-12-01)

Optimal Strategy for Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in High-Risk “TWILIGHT-like” Patients With Diabetes Mellitus
by: Hao-Yu Wang, et al.
Published: (2020-11-01)

One-year clinical outcomes in patients with very small coronary artery disease treated with drug-eluting stents: An observational study in the Indian population
by: Suhas P. Hardas, et al.
Published: (2021-11-01)

How Do Lipoprotein(a) Concentrations Affect Clinical Outcomes for Patients With Stable Coronary Artery Disease Who Underwent Different Dual Antiplatelet Therapy After Percutaneous Coronary Intervention?
by: Kongyong Cui, et al.
Published: (2022-05-01)

DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE
by: G. N. Guseva, et al.
Published: (2015-09-01)

Clinical Outcomes of Very Short Term Dual Antiplatelet Therapy in Patients With or Without Diabetes Undergoing Second-Generation Drug-Eluting Stents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Xi-Ying Liang, et al.
Published: (2021-07-01)

The Role of Dual Antiplatelet in Stent-Assisted Coiling in Wide-Neck Aneurysm
by: Ricky Gusanto Kurniawan, et al.
Published: (2023-01-01)

Efficacy and Safety of Very Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Peng-Yu Zhong, et al.
Published: (2021-09-01)

Drug-eluting stents: long-term safety
by: Yu A Karpov, et al.
Published: (2009-05-01)

Antiplatelet Therapy in a Patient with Coronary Artery Disease and Myelodysplastic Syndrome with Thrombocytopenia
by: Francisco José Fernández-Fernández, et al.
Published: (2017-10-01)

Trends in antiplatelet strategies 12-months following coronary stent placement in anticoagulated patients
by: Eleni M. Gamvroulas, et al.
Published: (2023-03-01)

Emergency vertebrobasilar stenting in recurrent medial medullary ischemic stroke
by: Rahul Pathak, et al.
Published: (2020-01-01)

Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations
by: Kongyong Cui, et al.
Published: (2021-12-01)

Consensus Decision‐Making for the Management of Antiplatelet Therapy before Non‐Cardiac Surgery in Patients Who Underwent Percutaneous Coronary Intervention With Second‐Generation Drug‐Eluting Stents: A Cohort Study
by: Choongki Kim, et al.
Published: (2021-04-01)

Trends in Dual Antiplatelet Therapy Use for Neurointerventional Procedures for the Management of Intracranial Aneurysms
by: Benjamen M. Meyer, et al.
Published: (2023-08-01)

The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients
by: Fan ZG, et al.
Published: (2016-10-01)

Long term dual antiplatelet therapy after myocardial infarction: retrospective analysis in an outpatient population
by: Gennaro Ratti, et al.
Published: (2021-09-01)

Dual Antiplatelet Therapy Regimens and Duration for Intracranial Stenting Procedures: Literature Review
by: Milda Paliulytė, et al.
Published: (2023-11-01)

Structural and temporal dynamics analysis on drug-eluting stents: History, research hotspots and emerging trends
by: Lili Tan, et al.
Published: (2023-05-01)

Cardiology update
by: Sunil K Verma
Published: (2015-01-01)

Factors Related to Major Bleeding After Ticagrelor Therapy: Results from the TICO Trial
by: Jae Young Cho, et al.
Published: (2021-04-01)

“The unpredictable ABSORB” – very late stent thrombosis of bioresorbable vascular scaffold
by: Akshyaya Pradhan, et al.
Published: (2019-01-01)